Want to see HK:1388 full AI Analyst Report?
Top Page
Embry Holdings Limited
(1388)
Select Model
Select Model
Rating:43Neutral
Price Target:
HK$0.23
▼(-43.25% Downside)
Action:Reiterated
Date:08/06/26
The score is primarily held back by weak financial performance—ongoing net and operating losses and recently negative operating/free cash flow—despite strong gross margins and manageable leverage. Technicals add further pressure with a clear downtrend and negative MACD, while valuation is constrained by a negative P/E and no stated dividend yield.
Positive Factors
Strong Gross Margins
Sustained gross margins near 70–75% indicate that Embry’s products retain meaningful value relative to direct product costs. This provides a potentially attractive economic foundation and leaves room for the company to improve profitability if operating costs and sales productivity become better controlled.
Negative Factors
Persistent Operating Losses
Persistent operating and net losses show that strong gross margins are not translating into viable overall earnings. This points to elevated operating costs or weak operating leverage, limiting internal funding capacity and making sustained improvement dependent on restoring profitability rather than merely increasing sales.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Gross Margins
Sustained gross margins near 70–75% indicate that Embry’s products retain meaningful value relative to direct product costs. This provides a potentially attractive economic foundation and leaves room for the company to improve profitability if operating costs and sales productivity become better controlled.
Read all positive factors
Embry Holdings Limited (1388) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$99.27M
Dividend Yield4.09%
Average Volume (3M)20.87K
Price to Earnings (P/E)―
Beta (1Y)0.32
Revenue Growth5.51%
EPS Growth30.14%
CountryHK
Employees3,696
SectorConsumer Cyclical
Sector Strength84
IndustryApparel - Manufacturers
Share Statistics
EPS (TTM)-0.58
Shares Outstanding422,416,630
10 Day Avg. Volume25,400
30 Day Avg. Volume20,866
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.10
Price to Sales (P/S)0.13
P/FCF Ratio-4.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Embry Holdings Limited Business Overview & Revenue Model
Company Description
Embry Holdings Limited operates as an investment holding company primarily focused on the entire lifecycle of women's intimate apparel, encompassing design, research, development, manufacturing, and distribution. Its product offerings include bras...
How the Company Makes Money
Embry Holdings Limited makes money mainly by selling women’s lingerie and related intimate apparel products through branded channels. Its core revenue is generated from: (1) Retail sales via self-operated stores and counters, where the company ear...
Embry Holdings Limited Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
58
Neutral
Cash Flow
32
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.19B | 1.17B | 1.15B | 1.28B | 1.33B | 1.65B |
| Gross Profit | 823.14M | 818.45M | 848.67M | 956.10M | 1.00B | 1.21B |
| EBITDA | -90.14M | -87.83M | -268.27M | 15.40M | 65.16M | 131.00M |
| Net Income | -243.94M | -253.18M | -373.44M | -72.17M | -51.24M | -27.48M |
Balance Sheet | ||||||
| Total Assets | 2.45B | 2.32B | 2.37B | 2.86B | 2.98B | 3.30B |
| Cash, Cash Equivalents and Short-Term Investments | 229.35M | 189.79M | 163.43M | 283.61M | 380.18M | 378.64M |
| Total Debt | 574.60M | 476.52M | 363.43M | 342.33M | 384.05M | 425.35M |
| Total Liabilities | 892.35M | 775.23M | 642.66M | 704.09M | 704.47M | 788.50M |
| Stockholders Equity | 1.55B | 1.55B | 1.72B | 2.16B | 2.27B | 2.52B |
Cash Flow | ||||||
| Free Cash Flow | -45.33M | -37.17M | -90.39M | 9.81M | 116.54M | 154.28M |
| Operating Cash Flow | -36.85M | -26.61M | -81.62M | 37.95M | 137.71M | 166.04M |
| Investing Cash Flow | -50.05M | -17.95M | -8.73M | -17.00M | -27.45M | -11.54M |
| Financing Cash Flow | 53.96M | 41.05M | -3.11M | -101.46M | -74.50M | -215.72M |
Embry Holdings Limited Technical Analysis
Negative
0.40
Price Trends
0.25
Negative
0.27
Negative
0.31
Negative
Market Momentum
>-0.01
Negative
24.56
Positive
61.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1388, the sentiment is Negative. The current price of 0.4 is above the 20-day moving average (MA) of 0.24, above the 50-day MA of 0.25, and above the 200-day MA of 0.31, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 24.56 is Positive, neither overbought nor oversold. The STOCH value of 61.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1388.
Embry Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | HK$559.32M | 3.82 | 5.83% | 6.27% | -1.84% | 29.22% | |
62 Neutral | HK$57.57B | 10.80 | 12.10% | 5.43% | 1.86% | -27.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$3.14B | 11.15 | 9.33% | 6.24% | -1.56% | 53.99% | |
58 Neutral | HK$341.26M | 4.05 | 6.65% | 7.61% | 0.41% | ― | |
50 Neutral | HK$244.04M | -1.80 | -10.95% | 4.00% | -16.20% | -324.90% | |
43 Neutral | HK$99.27M | -0.41 | -15.72% | 4.09% | 5.51% | 30.14% |
* Consumer Cyclical Sector Average
HK:1388
Embry Holdings Limited
0.24
-0.15
-38.16%
HK:2313
Shenzhou International Group Holdings
38.30
-25.56
-40.03%
HK:0311
Luen Thai Holdings Limited
0.33
0.11
48.65%
HK:3322
Win Hanverky Holdings Limited
0.19
-0.01
-5.00%
HK:2199
Regina Miracle International (Holdings) Limited
2.57
0.66
34.93%
HK:2298
Cosmo Lady (China) Holdings Co. Ltd.
0.26
-0.08
-24.78%
Embry Holdings Limited Corporate Events
Embry Holdings Narrows Interim Loss as E-Commerce and Branding Drive Modest Growth
Aug 28, 2026
Embry Holdings Limited, a Hong Kong-listed intimate apparel manufacturer and retailer, focuses on lingerie and related products under brands including EMBRY FORM. The company has been shifting more resources to e-commerce channels while using cele...
Embry Holdings Sets August Board Meeting to Review Interim Results and Dividend
Aug 13, 2026
Embry Holdings Limited has scheduled a board meeting for 28 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The board will also consider the possible recommendation of an interim dividend, sig...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.